EXAGEN INC. 8-K

What Happened
Exagen Inc. (XGN) announced and reported its financial results for the quarter and year ended December 31, 2025 in an 8-K filed on March 10, 2026. The company furnished a press release with those results as Exhibit 99.1 to the filing. The report was made under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: March 10, 2026; reporting period: quarter and year ended December 31, 2025.
• Press release with the financial results is furnished as Exhibit 99.1 to the Form 8-K.
• Interactive XBRL cover page file is included as Exhibit 104 (Inline XBRL).
• Item cited in the 8-K: 2.02 (Results of Operations and Financial Condition); exhibits listed under Item 9.01(d).

Why It Matters
This filing notifies investors that Exagen has publicly reported its latest earnings and financial condition for Q4 and full-year 2025. Retail investors should review the furnished press release and any accompanying financial statements/XBRL data to see the company’s revenue, earnings or loss figures, and commentary on operations and outlook. Those details are the material facts that could affect valuation, guidance comparison, and investment decisions.